Grifols Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
9 result(s) found, displaying 1 to 9
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 1000 mg solution for injection for intravenous infusion vial.
-
Cancellation or suspensionRegulatory action due to The manufacturer requested in writing the revocation of their TGA conformity assessment certificates., effective 20/02/2019
-
Cancellation or suspensionRegulatory action due to The manufacturer requested in writing the revocation of their TGA conformity assessment certificates., effective 20/02/2019
-
Cancellation by sponsorRequested by Grifols Australia Pty Ltd
-
INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial (164550)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 1g in 20 mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 10g in 200 mL human normal immunoglobulin solution for intravenous infusion vial.
-
INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial (164551)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 5g in 100mL human normal immunoglobulin solution for intravenous infusion vial. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRATECT 5% 2.5g in 50mL human normal immunoglobulin solution for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Grifols Australia Pty Ltd- Instrument/analyser IVDs.